PO:18:276 | Use of anifrolumab in the treatment of difficult-to-treat manifestations in systemic lupus erythematosus: Antonella Grimaldi1, Giuseppe Alessandrini2, Laura Quarta1, Maria Rita Ricciardi1, Daniela Costanza1, Clara Minerba1, Eugenio Quarta1 | 1UOC Reumatologia Verona; 2Specialista Dermatologo in Libera Professione, Italy. Reumatismo [Internet]. 2025 Nov. 25 [cited 2026 Jun. 27];77(s1). Available from: https://www.reumatismo.org/reuma/article/view/2170